ECTE Financial Facts

Licensing revenue: 19.11K
Other income (expense), net: -102.88K
See Full Income Statement

Deferred revenue, net of current portion: 57.32K
Additional paid-in capital: 133.04M
See Full Balance Sheet

Echo Therapeutics (ECTE) Earnings

  |   Expand Research on ECTE
Next EPS Date 8/8/14 *Est. EPS Growth Rate -76.9% *Last Qtr.
Average EPS % Beat Rate +10.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -13.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/9/14 Q114 -$0.23-$0.31 +$0.08$19.11K$20K N/A Details
3/27/14 Q413 -$0.36-$0.40 +$0.04N/A$20K N/A Details
8/8/13 Q213 -$0.51-$0.81 +$0.30$22.56M$10M N/A Details
5/10/13 Q113 -$0.13-$0.10 -$0.03N/A$10K N/A Details
11/8/12 Q312 -$0.11-$0.09 -$0.02$30.9K$40K N/A Details
8/10/12 Q212 -$0.08-$0.07 -$0.01$30.9K$190K N/A Details
5/11/12 Q112 -$0.08-$0.07 -$0.01$30.93K$80K N/A Details
11/8/11 Q311 -$0.04N/A N/A N/AN/A N/A Details